Literature DB >> 22287607

Vasculoprotective effects of heme oxygenase-1 in a murine model of hyperoxia-induced bronchopulmonary dysplasia.

Angeles Fernandez-Gonzalez1, S Alex Mitsialis, Xianlan Liu, Stella Kourembanas.   

Abstract

Bronchopulmonary dysplasia (BPD) is characterized by simplified alveolarization and arrested vascular development of the lung with associated evidence of endothelial dysfunction, inflammation, increased oxidative damage, and iron deposition. Heme oxygenase-1 (HO-1) has been reported to be protective in the pathogenesis of diseases of inflammatory and oxidative etiology. Because HO-1 is involved in the response to oxidative stress produced by hyperoxia and is critical for cellular heme and iron homeostasis, it could play a protective role in BPD. Therefore, we investigated the effect of HO-1 in hyperoxia-induced lung injury using a neonatal transgenic mouse model with constitutive lung-specific HO-1 overexpression. Hyperoxia triggered an increase in pulmonary inflammation, arterial remodeling, and right ventricular hypertrophy that was attenuated by HO-1 overexpression. In addition, hyperoxia led to pulmonary edema, hemosiderosis, and a decrease in blood vessel number, all of which were markedly improved in HO-1 overexpressing mice. The protective vascular response may be mediated at least in part by carbon monoxide, due to its anti-inflammatory, antiproliferative, and antiapoptotic properties. HO-1 overexpression, however, did not prevent alveolar simplification nor altered the levels of ferritin and lactoferrin, proteins involved in iron binding and transport. Thus the protective mechanisms elicited by HO-1 overexpression primarily preserve vascular growth and barrier function through iron-independent, antioxidant, and anti-inflammatory pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287607      PMCID: PMC3331581          DOI: 10.1152/ajplung.00196.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  51 in total

1.  Hyperoxia-derived lung damage in preterm infants.

Authors:  Vineet Bhandari
Journal:  Semin Fetal Neonatal Med       Date:  2010-04-28       Impact factor: 3.926

Review 2.  Neonatal pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

Review 3.  Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease.

Authors:  Steven H Abman
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

4.  Biliverdin reductase: a major physiologic cytoprotectant.

Authors:  David E Baranano; Mahil Rao; Christopher D Ferris; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

Review 5.  Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronchopulmonary dysplasia.

Authors:  Kristina Bry; Anna Hogmalm; Erica Bäckström
Journal:  Semin Perinatol       Date:  2010-06       Impact factor: 3.300

6.  Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury.

Authors:  Leo E Otterbein; Brian S Zuckerbraun; Manabu Haga; Fang Liu; Ruiping Song; Anny Usheva; Christina Stachulak; Natalya Bodyak; R Neal Smith; Eva Csizmadia; Shivraj Tyagi; Yorihiro Akamatsu; Richard J Flavell; Timothy R Billiar; Edith Tzeng; Fritz H Bach; Augustine M K Choi; Miguel P Soares
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

7.  Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease.

Authors:  Muhammad Aslam; Rajiv Baveja; Olin D Liang; Angeles Fernandez-Gonzalez; Changjin Lee; S Alex Mitsialis; Stella Kourembanas
Journal:  Am J Respir Crit Care Med       Date:  2009-08-27       Impact factor: 21.405

Review 8.  Pathogenesis of bronchopulmonary dysplasia.

Authors:  Don Hayes; David J Feola; Brian S Murphy; Lori A Shook; Hubert O Ballard
Journal:  Respiration       Date:  2009-09-25       Impact factor: 3.580

9.  Up-regulation of heme oxygenase-I in alveolar macrophages of newly diagnosed asthmatics.

Authors:  T Harju; Y Soini; R Pääkkö; V L Kinnula
Journal:  Respir Med       Date:  2002-06       Impact factor: 3.415

10.  Developmental expression of heme oxygenase in the rat lung.

Authors:  Phyllis A Dennery; Christen S Lee; Berendera S Ford; Yi-Hao Weng; Guang Yang; Pamela A Rodgers
Journal:  Pediatr Res       Date:  2003-01       Impact factor: 3.756

View more
  17 in total

1.  Iloprost attenuates hyperoxia-mediated impairment of lung development in newborn mice.

Authors:  Nelida Olave; Charitharth Vivek Lal; Brian Halloran; Vineet Bhandari; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-28       Impact factor: 5.464

Review 2.  Novel regulators of endothelial barrier function.

Authors:  Dolly Mehta; Krishnan Ravindran; Wolfgang M Kuebler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-07       Impact factor: 5.464

3.  Genetic ablation of Bach1 gene enhances recovery from hyperoxic lung injury in newborn mice via transient upregulation of inflammatory genes.

Authors:  Masato Ito; Nobuhiko Nagano; Yukio Arai; Ryo Ogawa; Shingo Kobayashi; Yukiko Motojima; Hayato Go; Masanori Tamura; Kazuhiko Igarashi; Phyllis A Dennery; Fumihiko Namba
Journal:  Pediatr Res       Date:  2017-01-18       Impact factor: 3.756

Review 4.  Heme oxygenase in neonatal lung injury and repair.

Authors:  Phyllis A Dennery
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

5.  Interactive and independent effects of early lipopolysaccharide and hyperoxia exposure on developing murine lungs.

Authors:  Amrit Kumar Shrestha; Renuka T Menon; Ahmed El-Saie; Roberto Barrios; Corey Reynolds; Binoy Shivanna
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-09       Impact factor: 5.464

6.  Omeprazole induces heme oxygenase-1 in fetal human pulmonary microvascular endothelial cells via hydrogen peroxide-independent Nrf2 signaling pathway.

Authors:  Ananddeep Patel; Shaojie Zhang; Amrit Kumar Shrestha; Paramahamsa Maturu; Bhagavatula Moorthy; Binoy Shivanna
Journal:  Toxicol Appl Pharmacol       Date:  2016-10-08       Impact factor: 4.219

7.  Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia.

Authors:  Thilo J Witsch; Pawel Turowski; Elpidoforos Sakkas; Gero Niess; Simone Becker; Susanne Herold; Konstantin Mayer; István Vadász; Jesse D Roberts; Werner Seeger; Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-27       Impact factor: 5.464

Review 8.  Carbon monoxide in lung cell physiology and disease.

Authors:  Stefan W Ryter; Kevin C Ma; Augustine M K Choi
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-08       Impact factor: 4.249

9.  Suppression of inflammatory cell trafficking and alveolar simplification by the heme oxygenase-1 product carbon monoxide.

Authors:  Anuli C Anyanwu; J Kelley Bentley; Antonia P Popova; Omar Malas; Husam Alghanem; Adam M Goldsmith; Marc B Hershenson; David J Pinsky
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-14       Impact factor: 5.464

Review 10.  Animal models of bronchopulmonary dysplasia. The term mouse models.

Authors:  Jessica Berger; Vineet Bhandari
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-10       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.